cellulitis_erysipelas%20(pediatric)
CELLULITIS/ERYSIPELAS (PEDIATRIC)
Cellulitis is an acute spreading skin infection that may go deep, involving the subcutaneous tissues.
It typically occurs in areas where the skin integrity has been compromised.
May result from blood-borne spread of infection to the skin and subcutaneous tissues.
It is commonly caused by beta-hemolytic streptococci and Staphylococcus aureus in adults and Haemophilus influenzae type B in patients <3 year of age.

Patient Education

  • Advise on good personal hygiene & wound care
    • Cover draining wounds w/ clean bandage
    • Regularly bathe & wash hands after coming in contact w/ a wound
    • Avoid sharing or reusing items that came in contact w/ infected skin
    • Inspect interdigital toe spaces regularly especially if w/ lower extremity cellulitis
  • Immobilization & elevation of affected limb
    • Effects: May help to decrease swelling & pain especially if used early in the course of treatment
  • Dressings
    • Cool sterile saline dressing may be applied
    • Effects: Removes purulent exudate from ulcers or infected abrasions, may help to decrease local pain 
  • Compression Stockings
    • May help w/ edema
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 14 Mar 2019
Atopic dermatitis appears to impair sleep quality, but not sleep duration, in children, particularly in those with more severe diseases, according to a new study.
Jairia Dela Cruz, 3 days ago
Use of mirabegron in the treatment of men with overactive bladder (OAB) appears to effectively alleviate urgency and storage symptoms, but not reduce the frequency of micturition episodes, according to data from the MIRACLE study.
5 days ago
Drinking coffee confers benefits for recurrence of hepatocellular carcinoma (HCC) and survival following orthotopic liver transplantation, a study has found.
6 days ago
A recent study has shown that the short-term efficacy of tenofovir disoproxil fumarate (TDF) is superior to entecavir (ETV) for the treatment of acute-on-chronic-liver failure (ACLF) due to reactivation of chronic hepatitis B (CHB).